Your browser doesn't support javascript.
loading
Undetectable measurable residual disease is associated with improved outcomes in AML irrespective of treatment intensity.
Bazinet, Alexandre; Kadia, Tapan; Short, Nicholas J; Borthakur, Gautam; Wang, Sa A; Wang, Wei; Loghavi, Sanam; Jorgensen, Jeffrey; Patel, Keyur; DiNardo, Courtney; Daver, Naval; Alvarado, Yesid; Haddad, Fadi G; Pierce, Sherry; Nogueras Gonzalez, Graciela; Maiti, Abhishek; Sasaki, Koji; Yilmaz, Musa; Thompson, Philip; Wierda, William; Garcia-Manero, Guillermo; Andreeff, Michael; Jabbour, Elias; Konopleva, Marina; Huang, Xuelin; Kantarjian, Hagop; Ravandi, Farhad.
Afiliación
  • Bazinet A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Wang SA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Wang W; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Jorgensen J; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Patel K; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • DiNardo C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Alvarado Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Haddad FG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Nogueras Gonzalez G; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Maiti A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Thompson P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Wierda W; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Andreeff M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Huang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Blood Adv ; 7(13): 3284-3296, 2023 07 11.
Article en En | MEDLINE | ID: mdl-36884300
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos